Merad Yanis, Conrad Anne, Brosset Sophie, Schmidt Axel, Hanriat Camille, Lustig Sebastien, Laurent Frederic, Kolenda Camille, Roussel-Gaillard Tiphaine, Batailler Cecile, Ferry Tristan
Infectious Disease Department, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France.
Université Claude Bernard Lyon 1, Lyon, France.
Front Med (Lausanne). 2023 Aug 3;10:1224922. doi: 10.3389/fmed.2023.1224922. eCollection 2023.
Among carbapenem-resistant , metallo-beta-lactamase producing strains represent a growing therapeutic challenge. While the association of aztreonam and ceftazidime-avibactam has been investigated in recent years for the treatment of infections involving these strains, little to no clinical data support the use of this association for the treatment of bone and joint infections. We report two cases of complex bone and joint infections involving metallo-beta-lactamase-producing , successfully treated at our referral center with aztreonam and ceftazidime-avibactam for 12 weeks in continuous infusions through elastomeric infusors.
在耐碳青霉烯类细菌中,产金属β-内酰胺酶的菌株对治疗构成了越来越大的挑战。近年来,虽然已对氨曲南和头孢他啶-阿维巴坦联合用药治疗涉及这些菌株的感染进行了研究,但几乎没有临床数据支持将这种联合用药用于治疗骨和关节感染。我们报告了两例涉及产金属β-内酰胺酶细菌的复杂性骨和关节感染病例,在我们的转诊中心通过弹性输液器持续输注氨曲南和头孢他啶-阿维巴坦,成功治疗了12周。